Canadian Cancer Trials Group Bulletins


Recent Publication

There was one recent publication related to Canadian Cancer Trials Group OV.16 -- A Phase III Study of Cisplatin plus Topotecan Followed by Paciltaxel plus Carboplatin versus Paclitaxel Plus Carboplatin as First Line Chemotherapy in Women with Newly Diagnosed Advanced Epithelial Ovarian Cancer

Weberpals JI, Tu D, Squire JA, Amin MS, Islam S, Pelletier LB, O'Brien AM, Hoskins PJ, Eisenhauer EA. Breast cancer 1 (BRCA1) protein expression as a prognostic marker in sporadic epithelial ovarian carcinoma: an Canadian Cancer Trials Group OV.16 correlative study (ONLINE). Ann Oncol 2011; doi: 10.1093/annonc/mdq770